trending Market Intelligence /marketintelligence/en/news-insights/trending/lhi5so0rq686ff3ntfiora2 content esgSubNav
In This List

Tonix Pharmaceuticals names board member

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation

Blog

Using Credit Analytics to Avoid Mispricing Insurance Premiums

Blog

Post-Webinar Q&A: Integrating Climate Risks into Credit Risk Portfolios


Tonix Pharmaceuticals names board member

New York-based Tonix Pharmaceuticals Holding Corp. appointed Adeoye Olukotun to its board.

He succeeds Ernest Mario, who stepped down as a director.

Olukotun is CEO of CR Strategies LLC, a clinical research and development consulting firm. His previous roles include CEO of EpiGen Pharmaceuticals Inc. and former vice chairman and CEO of CardioVax Inc.

Tonix Pharmaceuticals has two therapeutic programs focused on post-traumatic stress disorder.